About this trial
This study is an unmatched, case-control study of 150 youth (Ages 7-17) with a parent reported Intellectual Developmental Disability (IDD) who present to Rady Children's Hospital Emergency Department with a Mental Health Crisis (MHC). Rady Children's Institute for Genomic Medicine (RCIGM) will collect biological samples (such as blood) of these participants to study their genomes, medical and psychiatric profiles to better understand specific characteristics that may predispose them to MHC's. The 150 youth will be compared to historical, publicly available cohorts of youth with IDD's
Eligibility criteria
Qualifiers
Aggression towards others
Severe agitation
Self-injury
Elopement
Disqualifiers
Already received any prior whole genome sequencing or exome sequencing
Unable to approach the family or patient for enrollment
Unable to obtain informed consent
family members are ineligible for participation in this study if they are known to not be genetically related to the child/adolescent participant and/or if they are a member of a protected research population.
Trial design
Treatments tested in this trial
- Genomic sequencing and molecular diagnostic results, if any.
- EHR-Based Network Model